Acquired resistance to irradiation or docetaxel is not associated with cross-resistance to cisplatin in prostate cancer cell lines

PURPOSE: Platinum chemotherapy can be considered to treat metastatic castration-resistant prostate cancer (mCRPC) with features of neuroendocrine differentiation. However, platinum compounds are generally only applied after the failure of multiple prior-line treatment options. This study investigate...

Descripción completa

Detalles Bibliográficos
Autores principales: Donix, Lukas, Erb, Holger H. H., Peitzsch, Claudia, Dubrovska, Anna, Pfeifer, Manuel, Thomas, Christian, Fuessel, Susanne, Erdmann, Kati
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article – Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114061/
https://www.ncbi.nlm.nih.gov/pubmed/35020044
http://dx.doi.org/10.1007/s00432-022-03914-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114061/
https://www.ncbi.nlm.nih.gov/pubmed/35020044
http://dx.doi.org/10.1007/s00432-022-03914-5

Ejemplares similares